دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S0190-9622(21)00852-5
Volume 85, Issue 1, July 2021, Pages A8, A11, A16, A18-A19, A24-A26, A28, A30, A32, A34-A35
JAAD Case Reports Article List
doi : 10.1016/S0190-9622(21)00854-9
Volume 85, Issue 1, July 2021, Pages A40-A41, A44-A45
Journal Based CME Instructions and Information
doi : 10.1016/S0190-9622(21)00855-0
Volume 85, Issue 1, July 2021, Page A46
Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis
Carmen M.MontagnonMDaStanislav N.TolkachjovMDbDedee F.MurrellMA, BMBCh, MDcMichael J.CamilleriMDadJulia S.LehmanMDad
doi : 10.1016/j.jaad.2020.11.076
Volume 85, Issue 1, July 2021, Pages 1-14
Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy
Carmen M.MontagnonMDaJulia S.LehmanMDabDedee F.MurrellMA, BMBCh, MDcMichael J.CamilleriMDabStanislav N.TolkachjovMDd
doi : 10.1016/j.jaad.2020.05.161
Volume 85, Issue 1, July 2021, Pages 18-27
Fairness and transparency in medical journals
Dirk M.ElstonMDaJane M.Grant-KelsMDbNikkiLevinMD, PhDcMuradAlamMDdEmily M.AltmanMDeRobert T.BrodellMDfgAnthony P.FernandezMDhM. YadiraHurleyMDiJohnMaizeMDaDesireeRatnerMDjJulieSchafferMDkJonathanKantorMD, MSCElm
doi : 10.1016/j.jaad.2020.10.027
Volume 85, Issue 1, July 2021, Pages 31-32
This Month in JAAD: July 2021
Dirk M.ElstonMD
doi : 10.1016/j.jaad.2021.04.039
Volume 85, Issue 1, July 2021, Page 33
July 2021: Lisinopril for delayed inflammatory responses to hyaluronic acid fillers after COVID-19 vaccinations
BrettSloanMD
doi : 10.1016/j.jaad.2021.04.073
Volume 85, Issue 1, July 2021, Page 34
July 2021: Quality of life and patient-reported outcome measures in dermatology
JonathanKantorMD, MSCE
doi : 10.1016/j.jaad.2021.04.094
Volume 85, Issue 1, July 2021, Page 35
Morphing concepts of morphea
Warren R.HeymannMD
doi : 10.1016/j.jaad.2021.04.084
Volume 85, Issue 1, July 2021, Pages 36-37
Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations
Yvonne E.ChiuMDaLeonidShmuylovichMD, PhDbTinaKiguradzeMScKatelynAndersonMDdCathrynSibbaldMDeMeghaTollefsonMDdElaineKunzlerMDfWynnis L.TomMDgKelsieBondMDhRegina-CelesteAhmadMD, PhDiMaria TeresaGarcia-RomeroMD, MPHjMahwishIrfanMDkKaitlynKollmanMDcRaeganHuntMD, PhDlSarah L.SteinMDmLisaArkinMDnVivianWongMD, PhDoElenaPopeMD, MSceHeidiJacobeMD, MSCSfHeather A.Brandling-BennettMDhKelly M.CordoroMDiLionelBercovitchMDoStephanie M.RangelPhDcXuerongLiuMSpAnikoSzaboPhDpAmy S.PallerMS, MDc
doi : 10.1016/j.jaad.2021.03.017
Volume 85, Issue 1, July 2021, Pages 38-45
The distribution of pediatric-onset morphea and site-based likelihood for extracutaneous complications has not been well characterized.
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases
Devon E.McMahonBAaErinAmersonMDbMishaRosenbachMDcJules B.LipoffMDcDannaMoustafaBSaAnishaTyagiBAaSeemal R.DesaiMDdeLars E.FrenchMDfgHenry W.LimMDhBruce H.ThiersMDiGeorge J.HruzaMD, MBAjKimberly G.BlumenthalMD, MSckLindy P.FoxMDbEsther E.FreemanMD, PhDal
doi : 10.1016/j.jaad.2021.03.092
Volume 85, Issue 1, July 2021, Pages 46-55
Cutaneous reactions after messenger RNA (mRNA)-based COVID-19 vaccines have been reported but are not well characterized.
Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland
Jonas A. Adalsteinsson, Sonal Muzumdar, Reid Waldman, Rong Wu, Jon Gunnlaugur Jonasson
doi : 10.1016/j.jaad.2021.02.042
Volume 85, Issue 1, July 2021, Pages 56-61
Metformin has anticarcinogenic properties and is also known to inhibit the sonic hedgehog pathway, but population-based studies analyzing the potential protective effect for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are needed.
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)
Eric L.SimpsonMDaSethFormanMDbJonathan I.SilverbergMD, PhD, MPHcMatthewZirwasMDdEmanualMaverakisMDeGeorgeHanMD, PhDfEmmaGuttman-YasskyMD, PhDfDanielMarnellMDgRobertBissonnetteMDhJillWaibelMDiFabio P.NunesMD, MMScjAmy M.DeLozierMPHjRobinetteAngleBSNjMargaretGamaloPhDjKatrinHolzwarthMDjOrinGoldblumMDjJinglinZhongMSkJonathanJanesMB, BCh, FRCPjKimPappMD, PhDl
doi : 10.1016/j.jaad.2021.02.028
Volume 85, Issue 1, July 2021, Pages 62-70
Baricitinib, an oral selective Janus kinase 1/Janus kinase 2 inhibitor, is being studied for moderate-to-severe atopic dermatitis (AD) in adults.
Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
Joseph F.MerolaMDaJerryBagelMDbPeterAlmgrenMSccMads A.R?pkePhDcKatja W.LophavenMSccNatacha StrangeVestMSccParbeerGrewalMDd
doi : 10.1016/j.jaad.2021.03.032
Volume 85, Issue 1, July 2021, Pages 71-78
Atopic dermatitis (AD) is a chronic inflammatory skin disease. Interleukin (IL) 13 is a type 2 cytokine that is key to the inflammation underlying AD. Tralokinumab is a first-in-class, fully human, monoclonal antibody that specifically binds with high affinity to IL-13, neutralizing it in AD. Immunomodulatory treatments may impair vaccine-induced immune responses.
The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study
KhalafKridinMD, PhDabYochaiSchonmannMD, MSccOrlyWeinsteinMD, MPHcdEnnoSchmidtMD, PhDaRalf J.LudwigMDaArnon D.CohenMD, PhDcd
doi : 10.1016/j.jaad.2021.02.087
Volume 85, Issue 1, July 2021, Pages 79-87
The burden of COVID-19 in patients with bullous pemphigoid (BP) and pemphigus is yet to be evaluated.
Mucocutaneous manifestations in children hospitalized with COVID-19
DavidAndina-MartinezMDaMontserratNieto-MoroMDbJose AntonioAlonso-CadenasMDaJuanA?on-HidalgoMDcAngelaHernandez-MartinMDdEstherPerez-SuarezMDaIsabelColmenero-BlancoMDdMaria IsabelIglesias-BouzaMDbJuliaCano-FernandezMDcAnaMateos-MayoMDdAntonioTorreloMDd
doi : 10.1016/j.jaad.2021.03.083
Volume 85, Issue 1, July 2021, Pages 88-94
Cutaneous manifestations in hospitalized children with SARS-CoV-2 have not been studied systematically.
Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study
Aditya K.GuptaMDabMaria S.SurprenantDPMcSteven E.KempersMDdDavid M.PariserMDeKjellRensfeldtMDfAmirTavakkolPhDg
doi : 10.1016/j.jaad.2020.06.055
Volume 85, Issue 1, July 2021, Pages 95-104
Onychomycosis is a recalcitrant fungal nail infection. Topical antifungal agents may be preferred over systemic agents due to lack of systemic adverse effects.
Clinical characteristics and histopathologic changes of morphea: A single-center, retrospective study of 137 patients
JeminKimMDKyung BaeChungMDYoung InLeeMDJiheeKimMD, PhDJu HeeLeeMD, PhD
doi : 10.1016/j.jaad.2020.11.006
Volume 85, Issue 1, July 2021, Pages 105-113
The clinicopathologic correlations and prognostic risk factors for refractory disease in morphea (localized scleroderma) are poorly described.
Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort
SmritiPrasadBSASamantha M.BlackBSJane L.ZhuBAShivaniSharmaBSHeidiJacobeMD, MSCS
doi : 10.1016/j.jaad.2020.10.093
Volume 85, Issue 1, July 2021, Pages 114-120
Demographic and clinical findings of patients with mucocutaneous morphea have not been well characterized, to our knowledge.
Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique
Neil B.NewmanMD, MSaChirayu G.PatelMD, MPHbGeorge X.DingPhDaJohn A.ZicMDcJeffreyZwernerMD, PhDcEvan C.OsmundsonMD, PhDaAustin N.KirschnerMD, PhDa
doi : 10.1016/j.jaad.2020.12.023
Volume 85, Issue 1, July 2021, Pages 121-127
Low-dose total skin electron beam therapy provides a durable treatment response for skin lesions caused by cutaneous T-cell lymphoma. We prospectively assessed the durability of response and quality of life for patients receiving low-dose total skin electron beam therapy using a novel rotational technique and dosing regimen.
Impact of the time interval between primary melanoma excision and sentinel node biopsy: A systematic review and meta-analysis
PabloVargas-MoraMDabLeonardoPeruilh-BagoliniMDaRubénGonz?lez-CuevasMDacPedroFerrer-RosendeMScd
doi : 10.1016/j.jaad.2021.01.020
Volume 85, Issue 1, July 2021, Pages 128-134
Obtaining a sentinel lymph node biopsy (SLNB) specimen is a standard staging procedure in the management of cutaneous melanoma. However, there is no consensus on the safe time interval between the primary melanoma biopsy procedure and the SLNB procedure.
Small molecule inhibitors and biologics in treating nail psoriasis: A systematic review and network meta-analysis
I-HsinHuangMDaPo-ChienWuMDbTing-HuaYangMDcdeHuaLiMSfYu-TingHuangMSgYing-ChihChengMDfhiPo-HsiuKuoPhDfYa-HanLeeMS PharmjkYu-ChenHuangMDcdeYu-KangTuDDS, PhDfl
doi : 10.1016/j.jaad.2021.01.024
Volume 85, Issue 1, July 2021, Pages 135-143
Various systemic immunomodulating therapies have been investigated to treat nail psoriasis, but the efficacy remains unclear.
Malnutrition in children with ichthyosis: Recommendations for monitoring from a multidisciplinary clinic experience
SilviaRodr?guez-Manch?nMDaConsueloPedr?n-GinerMD, PhDaElviraCa?edo-VillarroyaMDaRosa AnaMu?oz-CodoceoMD, PhDa?ngelaHern?ndez-Mart?nMD, PhDb
doi : 10.1016/j.jaad.2020.06.064
Volume 85, Issue 1, July 2021, Pages 144-151
Short stature has been reported in congenital ichthyoses (CI), but few data exist on patients' nutritional status.
Systematic review of Mohs micrographic surgery in children: Identifying challenges and practical considerations for successful application
HaniehZarghamMDAmorKhachemouneMD
doi : 10.1016/j.jaad.2020.09.052
Volume 85, Issue 1, July 2021, Pages 152-161
Few data exist to guide the application of Mohs micrographic surgery (MMS) in the pediatric population.
Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review
AtrinToussiBS, BAabVirginia R.BartonMDaStephanie T.LeMDaOma N.AgbaiMDaMaijaKiuruMD, PhDac
doi : 10.1016/j.jaad.2020.06.047
Volume 85, Issue 1, July 2021, Pages 162-175
Alopecia areata (AA) is an immune-mediated disease resulting in nonscarring hair loss. Systematic reviews on the psychosocial and psychiatric comorbidities, health-related quality of life, and interventions targeting psychosocial well-being are limited.
Network meta-analysis–based comparison of first-line steroid-sparing adjuvants in the treatment of pemphigus vulgaris and pemphigus foliaceus
Meng-SuiLeePhDabYi-ChunYehPhDcYu-KangTuPhDdTom C.ChanPhDe
doi : 10.1016/j.jaad.2020.08.028
Volume 85, Issue 1, July 2021, Pages 176-186
Steroid-sparing adjuvants may enhance oral glucocorticoid benefits in pemphigus treatment. Selecting the optimal therapeutic option among various first-line steroid-sparing adjuvants is often a clinical challenge due to the lack of head-to-head clinical trials.
Pain management in hidradenitis suppurativa and a proposed treatment algorithm
Kevin T.SavageMDaVinitaSinghMDbZarine S.PatelPhDcChristine A.YannuzziBAdAnne MarieMcKenzie-BrownMDbMichelle A.LowesMBBS, PhDeLauren A.V.OrensteinMDf
doi : 10.1016/j.jaad.2020.09.039
Volume 85, Issue 1, July 2021, Pages 187-199
Development of systemic lupus in patients with cutaneous lupus using the 2012 Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for systemic lupus erythematosus
Samantha M.BlackBSaFrancesWalockoMDaXilongLiPhDbBenjamin F.ChongMD, MSCSa
doi : 10.1016/j.jaad.2020.12.061
Volume 85, Issue 1, July 2021, Pages 200-202
Cutaneous manifestations of SARS-CoV-2: A 2-center, prospective, case-controlled study
LuisaUnterluggauerMDaIsabellaPospischilMDbChristophKrallPhDcSimonaSaluzzoMD, PhDaSusanneKimeswengerPhDbMarioKarolyiMD, MScdChristophWenischMDdBerndLamprechtMD, PhDeEmmanuellaGuenovaMD, PhDfStefanWinklerMDgCsillaViczenczovaPhDhAndreasBergthalerDVMhWolfgangWeningerMDaWolframHoetzeneckerMD, PhDbGeorgStaryMDa
doi : 10.1016/j.jaad.2021.03.064
Volume 85, Issue 1, July 2021, Pages 202-204
Utilization of Instagram by dermatology residency programs in the era of COVID-19
GabrielleSchwartzmanBSAzamQureshiMDAdam J.FriedmanMD
doi : 10.1016/j.jaad.2021.03.078
Volume 85, Issue 1, July 2021, Pages 204-206
COVID-19: A catalyst for innovative hybrid teledermatology workflows to increase access and improve patient care at a large group practice
Olga K.AfanasievMD, PhDaDorothy Y.HungPhD, MA, MPHbSherryYanPhDcSusan J.HuangMDaBryan K.ChoMD, PhDa
doi : 10.1016/j.jaad.2021.03.098
Volume 85, Issue 1, July 2021, Pages 206-209
Race, ethnicity, and comorbidities are critical factors in the diagnosis of telogen effluvium during the COVID-19 pandemic
AbigailClineMD, PhDabAshley KeyesJacobsMDcMairaFonsecaMDcJuliaWuMDdFalguniAsraniMDehBijanSafaiMDaSharonGlickMDgBeth N.McLellanMDfAmy J.McMichaelMDiShoshanaMarmonMD, PhDbeh
doi : 10.1016/j.jaad.2021.03.099
Volume 85, Issue 1, July 2021, Pages 209-211
Aquagenic pruritus in polycythemia vera: A cross-sectional study
EdytaLelonekMDa?ukaszMatusiakMDaTomaszWr?belMDbJacek C.SzepietowskiMDa
doi : 10.1016/j.jaad.2017.10.021
Volume 85, Issue 1, July 2021, Pages 211-213
Sex differences in the risk of diabetes mellitus among individuals with psoriasis: A retrospective cohort study in Québec, Canada
RaymondMilanMScaJacquesLeLorierMD, PhDbcIvan V.LitvinovMD, PhDdKaberiDasguptaMD, MScefElhamRahmePhDef
doi : 10.1016/j.jaad.2020.07.082
Volume 85, Issue 1, July 2021, Pages 213-215
Case series of corneal eye shield application for laser treatment of periocular port-wine stains in infancy
MargoLederhandlerMDabHanaJeonMDcHyeminPomerantzMDaLeonard J.BernsteinMDadRoy G.GeronemusMDab
doi : 10.1016/j.jaad.2020.07.094
Volume 85, Issue 1, July 2021, Pages 215-217
Impact of prior authorizations on dermatology patients: A cross-sectional analysis
Lisa N.GuoBSabVinod E.NambudiriMD, MBAab
doi : 10.1016/j.jaad.2020.07.095
Volume 85, Issue 1, July 2021, Pages 217-220
Optimal timing of postoperative patient telephone calls after Mohs micrographic surgery: A randomized controlled trial
RobertBednarekMDaCoryJonakBSbNicholasGoldaMDa
doi : 10.1016/j.jaad.2020.07.106
Volume 85, Issue 1, July 2021, Pages 220-221
Impact of summer camps for children with chronic skin conditions
JessicaWuBAaMarciaHogelingMDb
doi : 10.1016/j.jaad.2020.07.107
Volume 85, Issue 1, July 2021, Pages 222-224
Deja UV all over again: Theoretical risks of the unregulated direct-to-consumer infrared technologies
ShaliniTharejaMDaYasmineHumedaBSbGenevievePatrickBScArmand B.CognettaJr.MDade
doi : 10.1016/j.jaad.2020.08.003
Volume 85, Issue 1, July 2021, Pages 224-225
Patient crowdsourcing of dermatologic consults on a Reddit social media community
BrianChuBSaRamieFathyABaAlicia L.NoblesPhD, MSbJules B.LipoffMDc
doi : 10.1016/j.jaad.2020.08.009
Volume 85, Issue 1, July 2021, Pages 226-227
Autoimmune and dermatologic conditions associated with lichen sclerosus
Amy KalowitzBieberMDAlexa B.SteuerMD, MPHLaura E.MelnickMDPriscilla W.WongMSMiriam KeltzPomeranzMD
doi : 10.1016/j.jaad.2020.08.011
Volume 85, Issue 1, July 2021, Pages 228-229
Drug-induced skin ulcers: A disproportionality analysis from the WHO pharmacovigilance database
DorothéeDuronPharmDaSophieBlaiseMD, PhDcJean-LucCracowskiMD, PhDabMatthieuRoustitPharmD, PhDabCharlesKhouriPharmD, PhDabd
doi : 10.1016/j.jaad.2020.08.013
Volume 85, Issue 1, July 2021, Pages 229-232
Cross-sectional study reveals reduced odds of allergies in people with hidradenitis suppurativa
Stephanie L.SchellPhDHaoruiSunBSStevenMaczugaMSJoslyn S.KirbyMDAmanda M.NelsonPhD
doi : 10.1016/j.jaad.2020.08.014
Volume 85, Issue 1, July 2021, Pages 232-234
Examining the landscape of skin of color dermatoses: A cross-sectional study at an urban tertiary care center
RaveenaKhannaBAabMicahBelzbergMDaRayvaKhannaBAcAmy H.HuangMDaKyle A.WilliamsBSaJustinChoiBSaNishadhSutariaBSaMichael S.HongBSaYoukyung S.RohBAaSewonKangMDaCrystalAguhMDaShawn G.KwatraMDa
doi : 10.1016/j.jaad.2020.07.124
Volume 85, Issue 1, July 2021, Pages 234-237
A retrospective study on the clinicopathologic features of IgG/IgA pemphigus
Maressa C.CriscitoMDaJeffrey M.CohenMDaSiavashToosiMDbLauren A.PennMD, MSCEaCasey L.RossMDcJoyceParkMDaElyse M.LoveMDaJulia S.LehmanMDdNooshin K.BrinsterMDa
doi : 10.1016/j.jaad.2020.07.126
Volume 85, Issue 1, July 2021, Pages 237-240
A quantitative analysis of research publications focused on the top chief complaints in patients with skin of color
Simone N.B.MontgomeryBANadaElbulukMD, MSc
doi : 10.1016/j.jaad.2020.08.031
Volume 85, Issue 1, July 2021, Pages 241-242
Skin cancer prevention counseling in populations with elevated risk: An analysis of the Health Information National Trends Survey 5 Cycle 2
SheenaDesaiBSabKevin J.MooreMD, MPHaRebecca I.HartmanMD, MPHac
doi : 10.1016/j.jaad.2020.08.034
Volume 85, Issue 1, July 2021, Pages 242-245
Primary cutaneous adenoid cystic carcinoma: Characterizing US demographics, clinical course, and prognostic factors
SaraYumeenMDaFatima N.MirzaMPHaHumza N.MirzaMSbChristine J.KoMDacJeffrey M.CohenMDa
doi : 10.1016/j.jaad.2020.08.040
Volume 85, Issue 1, July 2021, Pages 245-247
Chargemasters and price transparency in dermatology
Frank E.ZurfleyMDaKendallShiffletMDbEric W.HosslerMDc
doi : 10.1016/j.jaad.2020.08.048
Volume 85, Issue 1, July 2021, Pages 247-249
Low gene expression of TNF, IL17A, IL23A, and IL12B in tumors: A safety surrogate to predict cancer survival associated with biologic therapies
NikolaiKlebanovMDabLourdes M.Perez-ChadaMD, MMScaSameerGuptaMD, MPhilaAlice B.GottliebMD, PhDcJoseph F.MerolaMD, MMSca
doi : 10.1016/j.jaad.2020.08.050
Volume 85, Issue 1, July 2021, Pages 249-252
Color shift as a mechanism for depth modulation of skin images
Katharine L.HanlonBFA, CCRCaKara N.ShahMD, PhDbJames M.GrichnikMD, PhDa
doi : 10.1016/j.jaad.2020.08.052
Volume 85, Issue 1, July 2021, Pages 252-254
Bidirectional association between alopecia areata and migraine: A nationwide population-based cohort study
Ying-XiuDaiMDab?Ying-HsuanTaiMD, MScbcd?Chih-ChiangChenMD, PhDabeYun-TingChangMD, PhDabTzeng-JiChenMD, PhDbfMu-HongChenMD, PhDbg
doi : 10.1016/j.jaad.2020.05.160
Volume 85, Issue 1, July 2021, Pages 254-256
Melanomas and stress patterns on the foot: A systematic review and meta-analysis
Kenneth K.ChoMBBSabcAnne E.CustPhDdYun MeganFooMBBSbGuy D.EslickDrPH, PhDe
doi : 10.1016/j.jaad.2020.08.078
Volume 85, Issue 1, July 2021, Pages 256-258
Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders
PimAartsMDAllard R.J.V.VossenMD, PhDHessel H.van der ZeeMD, PhDErrol P.PrensMD, PhDKelsey R.van StraalenMD
doi : 10.1016/j.jaad.2020.08.113
Volume 85, Issue 1, July 2021, Pages 258-260
Female pattern hair loss in men: A distinct clinical variant of androgenetic alopecia
Karolina L.KerkemeyerBHlthSci, MBBS (Hons)aLara Trindadede CarvalhoMDaRebekkaJerjenBMSc (Hons), MChDaJaredJohnMBBSaRodney D.SinclairMD, FACDaJoelPinczewskiMD, PhD, FRCPAbBevinBhoyrulMBBS, MRCPa
doi : 10.1016/j.jaad.2020.09.042
Volume 85, Issue 1, July 2021, Pages 260-262
Growth of private equity in dermatology through acquisitions and new clinic formation, 2018 to 2019
KiraSeigerMD, MBAabcElizabethTkachenkoMDadArashMostaghimiMD, MPA, MPHab
doi : 10.1016/j.jaad.2020.09.044
Volume 85, Issue 1, July 2021, Pages 263-264
Recognition of atopic keratoconjunctivitis during treatment with dupilumab for atopic dermatitis
JustineChengMDaLaiJiangMDaNicole C.MorrowMDaArminAvdicMD, MSaJanet A.FairleyMDbJennifer J.LingMDaMark A.GreinerMDa
doi : 10.1016/j.jaad.2020.09.046
Volume 85, Issue 1, July 2021, Pages 265-267
Unna boot efficacy in dermatologic diseases
GabriellaSanta LuciaBS, BAAlanSnyderMSCRJohnPlanteBSAlexandraRitterBSDirkElstonMD
doi : 10.1016/j.jaad.2020.11.027
Volume 85, Issue 1, July 2021, Pages 267-269
Spironolactone in the treatment of adolescent acne: A retrospective review
Hannah S.BermanBAaCarol E.ChengMDbMarciaHogelingMDb
doi : 10.1016/j.jaad.2020.11.044
Volume 85, Issue 1, July 2021, Pages 269-271
Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areata
PriyaManjalyBAabSara J.LiBSacElizabethTkachenkoBSadJustin M.KoMD, MBAeKristina J.LiuMD, MHSaDeborah A.ScottMDaMaryanne M.SennaMDfCara J.JoycePhDgArashMostaghimiMD, MPA, MPHaKathie P.HuangMDa
doi : 10.1016/j.jaad.2020.06.1034
Volume 85, Issue 1, July 2021, Pages 271-272
Overview of TikTok's most viewed dermatologic content and assessment of its reliability
CamilaVilla-RuizMPHabBinaKassamaliBAaDaniel R.MazoriMDaMichelleMinMD, MSaGabrielaCobosMDaAveryLaChanceMD, MPHa
doi : 10.1016/j.jaad.2020.12.028
Volume 85, Issue 1, July 2021, Pages 273-274
Revenue generation of dermatology inpatient consultations: A retrospective multi-institutional evaluation of academic hospital-based consults
Connie S.ZhongMD, MScabArashMostaghimiMD, MPA, MPHabDanielaKroshinskyMD, MPHacVinod E.NambudiriMD, MBAab
doi : 10.1016/j.jaad.2020.08.044
Volume 85, Issue 1, July 2021, Pages 275-276
Ethics of social media marketing by dermatologists
SonalMuzumdarBSaJane M.Grant-KelsMDbcMehdiFarshchianMD, PhDd
doi : 10.1016/j.jaad.2021.01.015
Volume 85, Issue 1, July 2021, Pages 277-278
Beyond JAAD July 2021: Articles of interest to dermatologists from the nondermatologic literature
AndrewBroninMDaRobertPhelpsMDbRobertSidburyMDc
doi : 10.1016/j.jaad.2021.04.009
Volume 85, Issue 1, July 2021, Pages 279-283
JAAD Game Changers?: Late growth of infantile hemangiomas in children >3 years of age: A retrospective study?,
SoniaKamathMD
doi : 10.1016/j.jaad.2021.02.017
Volume 85, Issue 1, July 2021, Page 284
JAAD Game Changers?: Sleep disturbances in children with moderate/severe atopic dermatitis: A case-control study?,
Colleen H.CottonMD
doi : 10.1016/j.jaad.2021.02.018
Volume 85, Issue 1, July 2021, Page 285
Adhesive tape for safe nail clipping
Cristina Diniz Borges Figueira deMelloMDaNilton GioiaDi ChiacchioMD, PhDbcNiltonDi ChiacchioMD, PhDb
doi : 10.1016/j.jaad.2021.03.058
Volume 85, Issue 1, July 2021, Pages e1-e2
Treatment of painful and deep fissures of the heel with topical timolol
Manoj KarbhariPawarMD
doi : 10.1016/j.jaad.2020.05.100
Volume 85, Issue 1, July 2021, Pages e3-e4
Monopolar electrosurgical tunneling combined with bipolar coagulation for bloodless resection of sessile benign skin lesions
RashiPangtiMDSomeshGuptaMD
doi : 10.1016/j.jaad.2020.01.015
Volume 85, Issue 1, July 2021, Pages e5-e6
Use of craniotomy hemostatic clips in the excision of large scalp tumors
JuanJimenez-CauheMDDariode Perosanz-LoboMDOscar M.Moreno-ArronesMD, PhDSoniaBea-ArdebolMD, PhDLuisRios-BucetaMD, PhD
doi : 10.1016/j.jaad.2020.01.020
Volume 85, Issue 1, July 2021, Pages e7-e8
Mortise and tenon–type elastic adhesive bandage for noninvasive closure of oozing wounds at areas of tension
T.P.AfraMDMuhammedRazmi TMD, DNB, MNAMSN.A. BishurulHafiMD
doi : 10.1016/j.jaad.2020.01.021
Volume 85, Issue 1, July 2021, Pages e9-e10
Self-made negative pressure drainage device by sterile infusion set and syringes
ZhimingChenMDaYiZhangMDbXinfengWuMDb
doi : 10.1016/j.jaad.2020.01.076
Volume 85, Issue 1, July 2021, Pages e11-e12
Kaolin-impregnated gauze for hemostasis following nail surgery
Jose W.RicardoMDShari R.LipnerMD, PhD
doi : 10.1016/j.jaad.2020.02.008
Volume 85, Issue 1, July 2021, Pages e13-e14
Onychoscopy made easier: The innovative use of an ointment carton for easy visualization of the nail apparatus
Sanober BurzinDaruwallaMDRavinaSurveMBBSSurajPaiMBBSMithaliJageMDAseemSharmaMDRachita S.DhuratMDSmitaGhateMD
doi : 10.1016/j.jaad.2019.11.022
Volume 85, Issue 1, July 2021, Pages e15-e16
#DermTwitter and digital mentorship in the COVID-19 era
David X.ZhengBAaKathleen M.MulliganBAaJeffrey F.ScottMDb
doi : 10.1016/j.jaad.2021.03.101
Volume 85, Issue 1, July 2021, Pages e17-e18
Real-world direct-to-patient teledermatology in a low-income, elderly population
AbigailClineMD, PhDabcCareyKimMDabcMarciaDeitzMDacAmilcarRizzoMDacAnilThagirisaMBBS, MPAdFalguniAsraniMDeBijanSafaiMDbcShoshanaMarmonMD, PhDace
doi : 10.1016/j.jaad.2021.01.038
Volume 85, Issue 1, July 2021, Pages e19-e20
Cost analysis of the use of buffered lidocaine 1%, epinephrine 1:100,000 with sodium bicarbonate in a 3:1 ratio over a 9:1 ratio
Albert G.WuMSaJadeConwayBAaBipashaRoyBAaLaurenBarazaniMSaAbigailClinePhD, MDbMarcHandlerMDb
doi : 10.1016/j.jaad.2020.12.091
Volume 85, Issue 1, July 2021, Pages e21-e22
Response to: “Cost analysis of the use of buffered lidocaine 1%, epinephrine 1:100,000 with sodium bicarbonate in a 3:1 ratio”
JürgHafnerMD
doi : 10.1016/j.jaad.2021.01.060
Volume 85, Issue 1, July 2021, Page e23
TikTok and dermatology: An opportunity for public health engagement
David X.ZhengBAaKathleen M.MulliganBAaJeffrey F.ScottMDb
doi : 10.1016/j.jaad.2021.02.050
Volume 85, Issue 1, July 2021, Pages e25-e26
Characterizing top educational TikTok videos by dermatologists in response to “TikTok and dermatology: An opportunity for public health engagement”
BinaKassamaliBAaCamilaVilla-RuizMPHabDaniel R.MazoriMDaMichelleMinMD, MSaGabriela A.CobosMDaAvery H.LaChanceMD, MPHa
doi : 10.1016/j.jaad.2021.02.051
Volume 85, Issue 1, July 2021, Pages e27-e28
Late-onset hidradenitis suppurativa: A cluster analysis of the National Italian Registry IRHIS
SimoneCazzanigaPhDabElenaPezzoloMDacdSimoneGarcovichPhD, MDefLuigiNaldiMDad
doi : 10.1016/j.jaad.2021.02.075
Volume 85, Issue 1, July 2021, Pages e29-e32
The mode of action of tapinarof may not only depend on the activation of cutaneous aryl hydrocarbon receptor signaling but also on its antimicrobial activity
ThomasHaarmann-StemmannPhDaThomas R.SutterPhDbJeanKrutmannMDacCharlotteEsserPhDa
doi : 10.1016/j.jaad.2021.01.103
Volume 85, Issue 1, July 2021, Pages e33-e34
The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarof
RobertBissonnetteMDaLinda SteinGoldMDbDavid S.RubensteinMD, PhDcAnna M.TallmanPharmDdApril W.ArmstrongMD, MPHe
doi : 10.1016/j.jaad.2021.03.005
Volume 85, Issue 1, July 2021, Pages e35-e36
Tapinarof-induced folliculitis: The paradigm of activation of the aryl hydrocarbon signaling pathway
Maria PolinaKonstantinouMDFatmaJendoubiMDSalamaHegazyMDAmelBouznadMDMarieTauberMDCristinaBulai-LivideanuMDCarlePaulMD, PhD
doi : 10.1016/j.jaad.2021.01.104
Volume 85, Issue 1, July 2021, Pages e37-e38
Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapy
RobertBissonnetteMDaLinda SteinGoldMDbDavid S.RubensteinMD, PhDcAnna M.TallmanPharmDdApril W.ArmstrongMD, MPHe
doi : 10.1016/j.jaad.2021.03.006
Volume 85, Issue 1, July 2021, Pages e39-e40
Field cancerization in the skin: Past errors repeated
SarahMortonMBBSaJamesMuirMBBS, FACDbc
doi : 10.1016/j.jaad.2020.12.094
Volume 85, Issue 1, July 2021, Page e41
Field cancerization: Looking to the future
Tyler J.WillenbrinkMDaEmily S.RuizMD, MPHbChristine M.CornejoMDbChrysalyne D.SchmultsMD, MSCEbSarah T.ArronMD, PhDcAnokhiJambusaria-PahlajaniMD, MSCEa
doi : 10.1016/j.jaad.2021.02.077
Volume 85, Issue 1, July 2021, Pages e43-e44
Pemphigus management guidelines: A life-saving perspective
SaadiaTabassumMBBS, FCPS DermatologyaAtiyaRahmanMBBS, FCPS Dermatology, MMEdb
doi : 10.1016/j.jaad.2021.01.105
Volume 85, Issue 1, July 2021, Pages e45-e46
Individual patients’ risk factors impact guidelines for prophylactic agents used in pemphigus patients treated with rituximab
Dedee F.MurrellMD, PhDaPascalJolyMD, PhDbVictoria P.WerthMDcd
doi : 10.1016/j.jaad.2021.03.018
Volume 85, Issue 1, July 2021, Pages e47-e48
Trends in psoriasis treatments may differ for new and established patients
Mytrang H.DoPhDaShari R.LipnerMD, PhDb
doi : 10.1016/j.jaad.2021.02.088
Volume 85, Issue 1, July 2021, Pages e49-e50
Studies of single and multiple institutions may illustrate different treatment practices for psoriasis
SurajMuddasaniBSaAlan B.FleischerJr.MDbSteven R.FeldmanMD, PhDcdef
doi : 10.1016/j.jaad.2021.03.049
Volume 85, Issue 1, July 2021, Pages e51-e52
Improving cultural competency and practicing cultural humility in dermatologic training: Skin of color education and board certification
TrishaKaundinyaBS, BARoopal V.KunduMD
doi : 10.1016/j.jaad.2021.03.060
Volume 85, Issue 1, July 2021, Pages e53-e54
Comment on: “Skin biopsy and skin cancer treatment use in the Medicare population, 1993 to 2016”
PartikSinghMD, MBAaSylvanaBrickleyMSN, FNP-BC, DCNPaVeronicaRichardsonMSN, CRNP, ANP-BC, DCNPbJohn S.BarbieriMD, MBAb
doi : 10.1016/j.jaad.2021.03.062
Volume 85, Issue 1, July 2021, Pages e55-e56
Top authors in dermatology: Comparisons of standardized database citation indicators
Mindy D.SzetoMSaTorunn E.SivesindMDaColby L.PresleyBS, BAbTaylorHarpBAbAbigail L.MeckleyBSbAntaraAfrinBScSteven M.LadaBSaMelissa R.LaughterPhDaMayra B.C.MaymoneMDaRobert P.DellavalleMD, PhD, MSPHad
doi : 10.1016/j.jaad.2021.03.068
Volume 85, Issue 1, July 2021, Pages e57-e59
July iotaderma (#329)
Robert I.RudolphMD, FACP
doi : 10.1016/j.jaad.2021.01.001
Volume 85, Issue 1, July 2021, Page e61
June iotaderma (#328)
Robert I.RudolphMD, FACP
doi : 10.1016/j.jaad.2020.12.011
Volume 85, Issue 1, July 2021, Page e61
